CHINARES PHARMA (03320): Tasly Pharmaceutical Group's net profit for the first 9 months is about 992.5 million yuan, an increase of 19.85% year-on-year.
China Resources Pharmaceutical Group announced the unaudited financial information of Tianzhi Pharmaceutical for the nine months ended September 30, 2025.
CHINARES PHARMA (03320) announced the unaudited financial performance of Tasly Pharmaceutical Group for the nine months ended on September 30, 2025. The total operating income is approximately 6.311 billion yuan, a decrease of 2.35% year-on-year; the net profit is approximately 992.5 million yuan, an increase of 19.85% year-on-year.
Related Articles
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
